(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of FSCN1 mRNA CTD PMID:23649840 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of SNL mRNA CTD PMID:18247414 1,2-dimethylhydrazine increases expression ISO RGD:1615998 6480464 1, 2-Dimethylhydrazine results in increased expression of FSCN1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1615998 6480464 Ethinyl Estradiol affects the expression of FSCN1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1615998 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FSCN1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1615998 6480464 Ethinyl Estradiol results in increased expression of FSCN1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of FSCN1 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of FSCN1 mRNA CTD PMID:17404688 , PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FSCN1 mRNA CTD PMID:19167446 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1615998 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FSCN1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615998 6480464 Tetrachlorodibenzodioxin affects the expression of FSCN1 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FSCN1 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1615998 6480464 Tetrachlorodibenzodioxin results in decreased expression of FSCN1 mRNA CTD PMID:15652763 2-naphthylamine increases expression EXP 6480464 2-Naphthylamine results in increased expression of SNL mRNA CTD PMID:18247414 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1583309 6480464 3 more ... CTD PMID:32119087 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1615998 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FSCN1 mRNA CTD PMID:16054899 4-hydroxyphenyl retinamide increases expression ISO RGD:1615998 6480464 Fenretinide results in increased expression of FSCN1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects methylation EXP 6480464 Decitabine affects the methylation of FSCN1 gene CTD PMID:17630775 acetamide increases expression ISO RGD:1583309 6480464 acetamide results in increased expression of FSCN1 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1583309 6480464 Acrylamide results in decreased expression of FSCN1 mRNA CTD PMID:28959563 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of FSCN1 mRNA CTD PMID:15894607 , PMID:17218384 antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of FSCN1 mRNA CTD PMID:24449571 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FSCN1 protein] CTD PMID:26598702 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of FSCN1 mRNA CTD PMID:15070760 more ... ATP multiple interactions EXP 6480464 Niclosamide inhibits the reaction [Adenosine Triphosphate results in increased expression of FSCN1 mRNA] CTD PMID:29733962 ATP multiple interactions ISO RGD:1615998 6480464 Niclosamide inhibits the reaction [Adenosine Triphosphate results in increased expression of FSCN1 mRNA] CTD PMID:29733962 ATP increases expression ISO RGD:1615998 6480464 Adenosine Triphosphate results in increased expression of FSCN1 mRNA CTD PMID:29733962 ATP increases expression EXP 6480464 Adenosine Triphosphate results in increased expression of FSCN1 mRNA CTD PMID:29733962 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of SNL mRNA CTD PMID:18247414 benzo[a]pyrene increases expression ISO RGD:1615998 6480464 Benzoapyrene results in increased expression of FSCN1 mRNA CTD PMID:32417428 benzo[a]pyrene decreases methylation EXP 6480464 Benzoapyrene results in decreased methylation of FSCN1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1615998 6480464 Benzoapyrene results in decreased expression of FSCN1 mRNA CTD PMID:19770486 , PMID:22228805 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FSCN1 mRNA CTD PMID:23146750 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FSCN1 mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:1583309 6480464 bisphenol A affects the expression of FSCN1 mRNA CTD PMID:30816183 bisphenol A increases methylation ISO RGD:1583309 6480464 bisphenol A results in increased methylation of FSCN1 gene CTD PMID:28505145 buta-1,3-diene decreases expression ISO RGD:1615998 6480464 1, 3-butadiene results in decreased expression of FSCN1 mRNA CTD PMID:29038090 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of FSCN1 mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FSCN1 protein CTD PMID:24527689 carbon nanotube increases expression ISO RGD:1615998 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin affects expression EXP 6480464 chloropicrin affects the expression of FSCN1 mRNA CTD PMID:26352163 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of FSCN1 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1583309 6480464 latrunculin A affects the reaction [FSCN1 protein inhibits the reaction [CTNNA1 protein affects the susceptibility to Cisplatin]] CTD PMID:27989596 cisplatin affects response to substance ISO RGD:1583309 6480464 FSCN1 protein affects the susceptibility to Cisplatin CTD PMID:27989596 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of FSCN1 mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:1615998 6480464 Clofibrate results in decreased expression of FSCN1 mRNA CTD PMID:17585979 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FSCN1 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1615998 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FSCN1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1615998 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FSCN1 mRNA CTD PMID:15467011 coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of FSCN1 mRNA CTD PMID:19167446 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of FSCN1 mRNA CTD PMID:17403535 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of FSCN1 mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO RGD:1615998 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FSCN1 mRNA CTD PMID:16054899 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of FSCN1 mRNA CTD PMID:15070760 more ... diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FSCN1 protein] CTD PMID:26598702 diazinon increases methylation EXP 6480464 Diazinon results in increased methylation of FSCN1 gene CTD PMID:22964155 dibutyl phthalate decreases expression ISO RGD:1615998 6480464 Dibutyl Phthalate results in decreased expression of FSCN1 mRNA CTD PMID:21266533 dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of FSCN1 mRNA CTD PMID:28302478 dioxygen multiple interactions ISO RGD:1615998 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FSCN1 mRNA CTD PMID:30529165 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of FSCN1 mRNA CTD PMID:29803840 Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of FSCN1 mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FSCN1 protein CTD PMID:23301498 fenvalerate increases expression ISO RGD:1583309 6480464 fenvalerate results in increased expression of FSCN1 mRNA CTD PMID:30307764 hyaluronic acid decreases expression ISO RGD:1583309 6480464 Hyaluronic Acid analog results in decreased expression of FSCN1 protein CTD PMID:23178681 hyaluronic acid multiple interactions ISO RGD:1583309 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of FSCN1 protein] CTD PMID:23178681 hydrogen peroxide multiple interactions ISO RGD:1583309 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of FSCN1 protein] CTD PMID:23178681 hydrogen peroxide decreases expression ISO RGD:1583309 6480464 Hydrogen Peroxide results in decreased expression of FSCN1 protein CTD PMID:23178681 latrunculin A multiple interactions ISO RGD:1583309 6480464 latrunculin A affects the reaction [FSCN1 protein inhibits the reaction [CTNNA1 protein affects the susceptibility to Cisplatin]] CTD PMID:27989596 lipopolysaccharide multiple interactions EXP 6480464 FSCN1 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein], FSCN1 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] CTD PMID:22102721 lipopolysaccharide multiple interactions ISO RGD:1615998 6480464 FSCN1 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein], FSCN1 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] CTD PMID:22102721 lovastatin decreases expression ISO RGD:1615998 6480464 Lovastatin results in decreased expression of FSCN1 mRNA CTD PMID:20493250 lysophosphatidylcholine increases expression ISO RGD:1615998 6480464 Lysophosphatidylcholines results in increased expression of FSCN1 mRNA CTD PMID:22102721 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of FSCN1 protein CTD PMID:24736981 N-nitrosodiethylamine increases expression ISO RGD:1615998 6480464 Diethylnitrosamine results in increased expression of FSCN1 mRNA CTD PMID:24535843 Niclosamide multiple interactions ISO RGD:1615998 6480464 Niclosamide inhibits the reaction [Adenosine Triphosphate results in increased expression of FSCN1 mRNA] CTD PMID:29733962 Niclosamide multiple interactions EXP 6480464 Niclosamide inhibits the reaction [Adenosine Triphosphate results in increased expression of FSCN1 mRNA] CTD PMID:29733962 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of SNL mRNA CTD PMID:18247414 paclitaxel increases response to substance EXP 6480464 FSCN1 protein results in increased susceptibility to Paclitaxel CTD PMID:16734730 pentanal increases expression EXP 6480464 pentanal results in increased expression of FSCN1 mRNA CTD PMID:26079696 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of FSCN1 protein CTD PMID:22609092 , PMID:26879310 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1615998 6480464 FSCN1 mutant form affects the expression of [Tetradecanoylphorbol Acetate results in increased expression of TNF protein] CTD PMID:22102721 phorbol 13-acetate 12-myristate increases expression ISO RGD:1615998 6480464 Tetradecanoylphorbol Acetate results in increased expression of FSCN1 mRNA CTD PMID:22102721 pioglitazone decreases expression EXP 6480464 Pioglitazone results in decreased expression of FSCN1 mRNA CTD PMID:30031879 pirinixic acid increases expression ISO RGD:1615998 6480464 pirinixic acid results in increased expression of FSCN1 mRNA CTD PMID:18301758 progesterone multiple interactions EXP 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of FSCN1 mRNA CTD PMID:17404688 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of FSCN1 mRNA CTD PMID:26079696 quartz affects expression EXP 6480464 Quartz affects the expression of FSCN1 protein CTD PMID:27917503 quinoline increases expression EXP 6480464 quinoline analog results in increased expression of FSCN1 protein CTD PMID:18645022 silicon dioxide affects secretion EXP 6480464 Silicon Dioxide analog affects the secretion of FSCN1 protein CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1615998 6480464 Silicon Dioxide results in increased expression of FSCN1 mRNA CTD PMID:29341224 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of FSCN1 protein CTD PMID:27917503 silver atom increases expression EXP 6480464 Silver results in increased expression of FSCN1 mRNA CTD PMID:28959546 silver atom increases expression ISO RGD:1615998 6480464 Silver results in increased expression of FSCN1 mRNA CTD PMID:27131904 silver(0) increases expression EXP 6480464 Silver results in increased expression of FSCN1 mRNA CTD PMID:28959546 silver(0) increases expression ISO RGD:1615998 6480464 Silver results in increased expression of FSCN1 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1583309 6480464 sodium arsenite results in decreased expression of FSCN1 protein CTD PMID:29459688 succimer multiple interactions ISO RGD:1615998 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FSCN1 mRNA CTD PMID:21641980 T-2 toxin affects expression ISO RGD:1583309 6480464 T-2 Toxin affects the expression of FSCN1 protein CTD PMID:26141394 tamoxifen affects expression ISO RGD:1615998 6480464 Tamoxifen affects the expression of FSCN1 mRNA CTD PMID:17555576 , PMID:20937368 tebuconazole decreases expression EXP 6480464 tebuconazole results in decreased expression of FSCN1 mRNA CTD PMID:30458266 tetrachloromethane affects expression ISO RGD:1615998 6480464 Carbon Tetrachloride affects the expression of FSCN1 mRNA CTD PMID:17484886 trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of FSCN1 mRNA CTD PMID:28542535 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of FSCN1 mRNA CTD PMID:19140230 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of FSCN1 mRNA CTD PMID:22378314 , PMID:29453283 urethane increases expression EXP 6480464 Urethane results in increased expression of FSCN1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1615998 6480464 Valproic Acid affects the expression of FSCN1 mRNA CTD PMID:17292431 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of FSCN1 mRNA CTD PMID:23179753 more ... valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of FSCN1 mRNA CTD PMID:25979313 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of FSCN1 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:1615998 6480464 Vancomycin results in decreased expression of FSCN1 mRNA CTD PMID:18930951 vincristine increases expression EXP 6480464 Vincristine results in increased expression of FSCN1 mRNA CTD PMID:23649840 warfarin decreases expression ISO RGD:1615998 6480464 Warfarin results in decreased expression of FSCN1 mRNA CTD PMID:20493250 zinc sulfate affects expression EXP 6480464 Zinc Sulfate affects the expression of FSCN1 protein CTD PMID:25162517 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of FSCN1 mRNA CTD PMID:20977926